HX-301
- Generic Name
- HX-301
ON 123300 (Narazaciclib) and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma
Phase 1
Recruiting
- Conditions
- Relapsed and/or Refractory Multiple Myeloma
- Interventions
- First Posted Date
- 2024-04-08
- Last Posted Date
- 2024-10-03
- Lead Sponsor
- Adriana Rossi
- Target Recruit Count
- 36
- Registration Number
- NCT06351644
- Locations
- 🇺🇸
Mount Sinai Health System, New York, New York, United States
The Tolerability and Pharmacokinetics of HX301 Monolactate Capsules in Patients With Advanced Solid Tumors
- First Posted Date
- 2023-02-16
- Last Posted Date
- 2024-06-18
- Lead Sponsor
- Hangzhou Hanx Biopharmaceuticals, Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT05731934
- Locations
- 🇨🇳
National center/cancer hospital,chinese Academy of Medical Sciences and Peking Union Medicial College, Beijing, Beijing, China
Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic Malignancies
Phase 1
Recruiting
- Conditions
- Endometrioid Endometrial Cancer
- Interventions
- First Posted Date
- 2023-01-30
- Last Posted Date
- 2023-12-12
- Lead Sponsor
- Traws Pharma, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT05705505
- Locations
- 🇺🇸
NYU Langone, New York, New York, United States
🇺🇸Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, Texas, United States
🇺🇸Arizona Oncology Associates, PC - HOPE, Tucson, Arizona, United States
Study of ON 123300 in Patients With Advanced Cancer
- First Posted Date
- 2021-02-04
- Last Posted Date
- 2023-12-07
- Lead Sponsor
- Traws Pharma, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT04739293
- Locations
- 🇺🇸
Mary Crowley Cancer Research, Dallas, Texas, United States
🇺🇸Greenville Health System, Institute for Oncology Clinical Research, Greenville, South Carolina, United States
🇺🇸START Midwest, Grand Rapids, Michigan, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath